Azad AF, Radulovic S, Higgins JA, Noden BH, Troyer JM, 1997. Flea-borne rickettsioses: ecologic considerations. Emerg Infect Dis 3 :319–327.
Stuart BM, Pullen RL, 1945. Endemic (murine) typhus fever: clinical observations of 180 cases. Ann Intern Med 23 :520–536.
Azad AF, Traub R, Wisseman CL, 1983. Rickettsia mooseri infection in the fleas Leptopsylla segnis and Xenopsylla cheopis.Am J Trop Med Hyg. 32 :1392–1400.
Dimissas KA, 1948. Epidemic diseases transmitted by insects. Med Sci Pract 2 :517–560.
Chaniotis B, Psarulaki A, Chaliotis G, Gozalo Garcia G, Gozadinos T, Tselentis Y, 1994. Transmission cycle of murine typhus in Greece. Ann Trop Med Parasitol 88 :645–647.
Rolain JM, Maurin M, Vestris G, Raoult D, 1998. In vitro susceptibilities of 27 Rickettsiae to 13 antimicrobials. Antimicrob Agents Chemother 42 :1537–1541
Tselentis Y, Babalis TL, Chrysanthis D, Gikas A, Chaliotis G, Raoult D, 1992. Clinicoepidemiological study of murine typhus on the Greek island of Evia. Eur J Epidemiol 8 :268–272.
Dumler JS, Taylor JP, Walker DH, 1991. Clinical and laboratory features of murine typhus in south Texas, 1980 through 1987. JAMA 266 :1365–1370.
Tselentis Y, Edlinger E, Alexious G, Chrysantis D, Levendis A, 1986. An endemic focus of murine typhus in Europe. J Infect 13 :91–92.
Gikas A, Doukakis S, Pediaditis J, Kastanakis S, Psaroulaki A, Tselentis Y, 2002. Murine typhus in Greece: epidemiological, clinical, and therapeutic data from 83 cases. Trans R Soc Trop Med Hyg 96 :250–253.
Strand O, Stromberg A, 1990. Ciprofloxacin treatment of murine typhus. Scand J Infect Dis 22 :503–504.
Rault D, Drancourt M, 1991. Antimicrobial therapy of rickettsial diseases. Antimicrob Agents Chemother 35 :2457–2462.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1 | 1 | 1 |
Full Text Views | 351 | 160 | 2 |
PDF Downloads | 80 | 33 | 1 |
This study estimated the clinical effectiveness of five different antibiotic regimens (doxycycline, chloramphenicol, ciprofloxacin, doxycycline plus chloramphenicol, and doxycycline plus ciprofloxacin) administered for infection with Rickettsia typhi in terms of the duration of the fever. Eighty-seven patients with endemic typhus were hospitalized between 1993 and 1998 at the General Hospital of Chania in Chania, Crete, Greece. The mean time to defervescence was 2.9 days for doxycycline, 4.0 days for chloramphenicol, and 4.2 days for ciprofloxacin. In patients receiving combinations of doxycycline plus chloramphenicol and doxycycline plus ciprofloxacin, fever subsided in 3.4 and 4.0 days, respectively. The outcome was favorable in all patients, and no deaths or relapses were observed within two months.